The House of Representatives has approved H.R.1919, the “track and trace” legislation that includes provisions for both lot-level and unit-level tracking of pharmaceutical products throughout the supply chain.
More information on the legislation, and steps on how to prepare, can be found here.
Senate Subcommittee Approves Pharmaceutical Compounding Quality and Accountability Act
House Committee Approves Drug “Track and Trace” Bill
Presenters: Jim Gilligan, American Medical AssociationEve Poczatek, MBA, SPHR, Rush University System for Health
Comments are closed.
